Movement Alert|Exelixis Falls 4.07% in Regular Trading, Analyst Target Cuts Weigh on Sentiment

Market Focus11-19 23:57

On November 19, Exelixis fell 4.07% in Regular Trading, trading at $65.64/share, with turnover of $38.00 million.

The move appears tied to weaker analyst sentiment after Morgan Stanley cut its price target to $57 from $60, while RBC had earlier raised its target to $58 from $51 but kept a Sector Perform rating.

That pressure came despite solid quarterly results reported in late October: adjusted EPS was $0.94, above estimates ranging from $0.80 to $0.89, and revenue rose to $658.7 million from $597.8 million, also ahead of consensus. For full-year revenue, Exelixis guided to $2.50 billion to $2.55 billion, with the high end only in line with market expectations, which may have limited upside enthusiasm.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment